Literature DB >> 5647965

[Treatment of hemophilia B with PPSB].

E A Loeliger, M J Mattern, A Hensen, H C Hemker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5647965     DOI： 10.1007/BF01631778

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  5 in total

1.  ["COAGULANT" FRACTIONS CONTAINING COAGULATION FACTORS ADSORBABLE BY TRICALCIC PHOSPHATE].

Authors:  J P SOULIER; C BLATRIX; M STEINBUCH
Journal:  Presse Med       Date:  1964-04-25       Impact factor: 1.228

2.  THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).

Authors:  C F ABILDGAARD; J A CORNET; E FORT; I SCHULMAN
Journal:  Br J Haematol       Date:  1964-04       Impact factor: 6.998

3.  [Preparation of a fraction rich in prothrombin, proconvertin, Stuart factor and antihemophilic factor B (P.P.B. fraction)].

Authors:  C BLATRIX; J P SOULIER
Journal:  Pathol Biol       Date:  1959-12

4.  Substitution therapy in haemophilia B.

Authors:  E A LOELIGER; A HENSEN
Journal:  Thromb Diath Haemorrh       Date:  1961-12-15

5.  Detection of heterozygotes for factor 8, 9, and 12 deficiency.

Authors:  J J Veltkamp; H C Hemker; E A Loeliger
Journal:  Thromb Diath Haemorrh Suppl       Date:  1965
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.